Seeking Alpha

Testing of Gilead's remdesivir in coronavirus patients to start tomorrow in China

|About: Gilead Sciences, Inc. (GILD)|By: , SA News Editor

China's state-run Xinhua News Agency reports that healthcare providers at Wuhan's Jinyintan Hospital will begin treating the first group of severe coronavirus cases with Gilead Sciences' (GILD -2.2%) remdesivir tomorrow. A total of 761 patients will receive therapy.

Chinese authorities have OK'd the start of clinical trials.